VEGF receptor 1 stimulates stem-cell recruitment and new hope for angiogenesis therapies
Ulf Eriksson1
& Kari Alitalo2
1
Ludwig Institute for Cancer Research, Stockholm Branch, Stockholm, Sweden
2
Molecular/Cancer Biology Laboratory and Ludwig Institute for Cancer Research, Haartman Institute and Biomedicum Helsinki, University of Helsinki, Finland kari.alitalo@helsinki.fi
Efforts to control vessel growth have focused on vascular endothelial growth factor (VEGF) and its primary receptor VEGFR-2. New data could shift that focus to other members of the VEGF family and the receptor VEGFR-1, particularly in inflammatory diseases (pages 831−840 & 841−849).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
